Artiva Biotherapeutics awarded President and Head of R&D Miralles Gines Diego 45,000 shares at $0 per share on Sep. 9, 2026. The transaction lifted his reported common-share holding to 122,500 shares, representing about 36.7% of the resulting holding, while a separate award left him with 135,000 derivative securities.
Key Highlights
- Artiva Biotherapeutics awarded Miralles Gines Diego 45,000 shares at $0 per share on Sep. 9, 2026.
- Diego owned 122,500 Artiva Biotherapeutics shares after the transaction, representing about 36.7% of his resulting shareholding.
- A separate award covered 135,000 derivative securities, leaving Diego with 135,000 derivative securities.
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) awarded President and Head of R&D Miralles Gines Diego 45,000 shares at $0 per share on Sep. 9, 2026. The transaction was recorded under code A, an award or grant classification.
Share Award and Derivative Securities
The award left Diego with 122,500 Artiva Biotherapeutics shares after the transaction. The same date also brought an award of 135,000 derivative securities. Diego’s resulting derivative-securities holding was 135,000. Both transactions carried the A classification, identifying them as awards or grants. The common-share award was issued at $0 per share.
Reported Ownership After the Award
The 45,000-share transaction represented about 36.7% of Diego’s resulting common-share holding. The derivative-securities transaction represented about 100.0% of his resulting derivative-securities holding. Those percentages apply to separate reported holding categories, with 122,500 shares and 135,000 derivative securities shown after the respective transactions.
FAQs
Q: What did Artiva Biotherapeutics award Miralles Gines Diego?
A: Artiva Biotherapeutics awarded Miralles Gines Diego 45,000 shares at $0 per share. He also received 135,000 derivative securities on Sep. 9, 2026.
Q: How did the Artiva Biotherapeutics award affect reported ownership?
A: Following the transaction, Diego owned 122,500 Artiva Biotherapeutics shares. The 45,000-share award represented about 36.7% of his resulting shareholding, according to the filing.
Q: What does transaction code A mean for the ARTV stock award?
A: Transaction code A identifies the ARTV transaction as an award or grant. The filing reported 45,000 shares in the award and 135,000 resulting derivative securities.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.